IGMPI facebook Clinical Research
IGMPI Logo
Faculty of Clinical Research and Drug Safety

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

Competency based placement focussed Education I Training I Research I Consultancy

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular | Part-time (Online Live Classes) Modes

Clinical Research

Merck’s phase 3 KEYNOTE-811 trial of Keytruda in combo with trastuzumab and fluoropyrimidine- and platinum-containing chemotherapy meets dual primary endpoint of OS in patients with HER2-positive ad
Micron reveals positive data from needle-free measles and rubella vaccine study
Micron Medical's Phase I/II trial, detailed in The Lancet, underscores the safety and efficacy of its measles and rubella microneedle patch (MNP), offering a needle-free vaccination option. Results sh
Newron’s add-on schizophrenia therapy mets endpoints in Phase II/III trial
LEO Pharma declares positive data from Phase III plaque psoriasis trial
AstraZeneca declares positive interim data from mantle cell lymphoma trial
AngioDynamics touts positive data from AlphaVac trial
Boehringer declares positive findings from diabetic macular ischemia trial
Merck’s trial of Keytruda regimen fails to meet primary endpoint
Teva and Medincell declared positive data for TEV-‘749 in schizophrenia trial
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
Roche targets obesity market with early positive trial data
Vanda Pharmaceuticals declares positive data from motion sickness trial
SPR Therapeutics announces positive data for PNS pain relief device
Novo Nordisk reports positive results from Phase IIIa trial of haemophilia A drug